Science and Technology  Committee - Third Report
Clinical Trials

Here you can browse the report together with the Proceedings of the Committee. The published report was ordered by the House of Commons to be printed 9 September 2013.


Terms of Reference


1 Introduction

2 Regulation and governance of UK trials

3 Barriers to conducting trials in the UK

4 Clinical trial transparency

5 Conclusions

Conclusions and recommendations

Formal Minutes


List of printed written evidence

List of additional written evidence

List of Reports from the Committee during the current Parliament

Oral and written evidence

Wednesday 13 March 2013: Professor Sir Michael Rawlins, Chair of the Academy of Medical Sciences Working Group on the Regulation and Governance of Health Research, Dr Keith Bragman, President of the Faculty of Pharmaceutical Medicine, and Dr Fiona Godlee, Editor in Chief of the British Medical Journal

Monday 22 April 2013: Dr Catherine Elliott, Director, Clinical Research Interests, Medical Research Council, Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities, Professor Peter Johnson, Chief Clinician, Cancer Research UK, and Nicola Perrin, Head of Policy, Wellcome Trust; Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry, Dr James Shannon, Chief Medical Officer, GlaxoSmithKline, William M Burns, Member of the Board of Directors, Hoffmann-La Roche, and Dr Ben Goldacre, Wellcome Research Fellow in Epidemiology, London School of Hygiene and Tropical Medicine

Wednesday 15 May 2013: Simon Denegri, NIHR National Director for Public Participation and Engagement in Research and Chair, INVOLVE, and Professor Karol Sikora, Medical Director of Cancer Partners UK and Dean, University of Buckingham Medical School; Tracey Brown, Managing Director, Sense About Science, and Dr Helen Jamison, Deputy Director, Science Media Centre; Bill Davidson, Acting Deputy Director and Head of Research Standards and Support, Department of Health, Peter Knight, Deputy Director, Head of Research Information and Intelligence, Department of Health, Dr Janet Wisely, Chief Executive, Health Research Authority, and Sir Kent Woods, Chief Executive, Medicines and Healthcare Products Regulatory Agency

Monday 3 June 2013: Rt Hon David Willetts MP, Minister of State for Universities and Science, Department for Business, Innovation and Skills, and Rt Hon Earl Howe, Parliamentary Under-Secretary of State for Quality, Department of Health

Written evidence

Additional written evidence

previous page contents next page

© Parliamentary copyright 2013
Prepared 17 September 2013